文献速递眼底病与葡萄膜炎

细胞通路中罕见预测功能丧失变异与年龄相关性黄斑变性亚表型的关联

Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration.
PubMed 文献 · Ophthalmology · 2017-12-08

基于AREDS、AREDS2和密歇根基因组计划的病例对照研究,分析52个AMD风险位点区域内罕见pLoF变异与AMD亚表型的关联。罕见pLoF变异整体与AMD无显著关联,但补体通路罕见pLoF变异在病例中富集,且与地图样萎缩、钙化玻璃膜疣相关;所有罕见pLoF变异与脉络膜新生血管、钙化玻璃膜疣、AREDS扩展严重度评分及进展为晚期疾病相关。

要点

  • 罕见pLoF变异在病例与对照间无显著差异(OR 1.11,95%CI 0.91-1.36,P=0.310)。
  • 补体通路罕见pLoF变异在病例中富集(OR 2.94,95%CI 1.49-5.79,P=0.002)。
  • 补体通路罕见pLoF变异与地图样萎缩(OR 2.17)和钙化玻璃膜疣(OR 3.75)相关。

核心结论

  • 罕见pLoF变异与疾病进展相关。
  • 补体通路变异修饰AMD临床病程并增加特定亚表型发生风险。

研究设计与样本

  • 病例对照研究,纳入AREDS、AREDS2和密歇根基因组计划参与者。
  • 对既往识别的52个独立AMD风险变异区域内的罕见pLoF变异(频率<0.1%)进行全基因组测序数据分析。
  • 比较中间型或晚期AMD病例与对照的罕见pLoF变异频率,并将变异分配至补体、细胞外基质(ECM)、脂质、细胞存活、免疫系统、代谢或未知/其他通路。
  • 采用logistic回归、线性回归和Cox比例风险模型分析罕见pLoF变异通路与AMD亚表型的关联。

主要发现

  • 罕见pLoF变异见于1689例病例中的298例(17.6%)和1518例对照中的237例(15.6%)(OR 1.11,95%CI 0.91-1.36,P=0.310)。
  • 补体通路罕见pLoF变异在病例较对照富集(OR 2.94,95%CI 1.49-5.79,P=0.002)。
  • 在病例中,所有罕见pLoF变异与脉络膜新生血管(CNV)相关(OR 1.34,95%CI 1.04-1.73,P=0.023),与钙化玻璃膜疣相关(OR 1.33,95%CI 1.04-1.72,P=0.025)。
  • 所有罕见pLoF变异与AREDS扩展AMD严重度量表更高评分相关(标准化系数β=0.346,95%CI 0.086-0.605,P=0.009),与进展为晚期疾病相关(HR 1.25,95%CI 1.01-1.55,P=0.042)。
  • 通路水平上,补体通路与地图样萎缩(GA)相关(OR 2.17,95%CI 1.12-4.24,P=0.023),补体通路与钙化玻璃膜疣相关(OR 3.75,95%CI 1.79-7.86,P<0.001),ECM通路与AREDS扩展AMD严重度量表更严重水平相关(β=0.62,95%CI 0.04-1.20,P=0.035)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the association of rare predicted loss-of-function (pLoF) variants within age-related macular degeneration (AMD) risk loci and AMD sub-phenotypes. DESIGN: Case-control study. PARTICIPANTS: Participants of AREDS, AREDS2, and Michigan Genomics Initiative. METHODS: Whole genome sequencing data were analyzed for rare pLoF variants (frequency <0.1%) in the regions of previously identified 52 independent risk variants known to be associated with AMD. Frequency of the rare pLoF variants in cases with intermediate or advanced AMD was compared with controls. Variants were assigned to the complement, extracellular matrix (ECM), lipid, cell survival, immune system, metabolism, or unknown/other pathway. Associations of rare pLoF variant pathways with AMD sub-phenotypes were analyzed using logistic and linear regression, and Cox proportional hazards models. MAIN OUTCOME MEASURES: Differences in rare pLoF variant pathway burden and association of rare pLoF variant pathways with sub-phenotypes within the population with AMD were evaluated. RESULTS: Rare pLoF variants were found in 298 of 1689 cases (17.6%) and 237 of 1518 controls (15.6%) (odds ratio [OR], 1.11; 95% confidence interval [CI], 0.91-1.36; P = 0.310). An enrichment of rare pLoF variants in the complement pathway in cases versus controls (OR, 2.94; 95% CI, 1.49-5.79; P = 0.002) was observed. Within cases, associations between all rare pLoF variants and choroidal neovascularization (CNV) (OR, 1.34; 95% CI, 1.04-1.73; P = 0.023), calcified drusen (OR, 1.33; 95% CI, 1.04-1.72; P = 0.025), higher scores on the AREDS Extended AMD Severity Scale (Standardized Coefficient Beta (β)=0.346 [0.086-0.605], P = 0.009), and progression to advanced disease (hazard ratio, 1.25; 95% CI, 1.01-1.55; P = 0.042) were observed. At the pathway level, there were associations between the complement pathway and geographic atrophy (GA) (OR, 2.17; 95% CI, 1.12-4.24; P = 0.023), the complement pathway and calcified drusen (OR, 3.75; 95% CI, 1.79-7.86; P < 0.001), and the ECM pathway and more severe levels in the AREDS Extended AMD Severity Scale (β = 0.62; 95% CI, 0.04-1.20; P = 0.035). CONCLUSIONS: Rare pLoF variants are associated with disease progression. Variants in the complement pathway modify the clinical course of AMD and increase the risk of developing specific sub-phenotypes.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Pietraszkiewicz A, van Asten F, Kwong A, et al. Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration. Ophthalmology. 2017. PMID: 29224928. doi:10.1016/j.ophtha.2017.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。